GBT 440 is a modulator of sickle hemoglobin (HbS), extracted from patent WO2015116061A1, compound 5, which can be used in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

本产品信息由（厦门慧嘉生物科技有限公司）为您提供，内容包括（GBT 440 is a modulator of sickle hemoglobin (HbS), extracted from patent WO2015116061A1, compound 5, which can be used in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.）的品牌、型号、技术参数、详细介绍等；如果您想了解更多关于（GBT 440 is a modulator of sickle hemoglobin (HbS), extracted from patent WO2015116061A1, compound 5, which can be used in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.）的信息，请直接联系供应商，给供应商留言。若当前页面内容侵犯到您的权益，请及时告知我们，我们将马上修改或删除。